Browse > Article

Linezolid Treatment for Osteomyelitis due to Staphylococcus Epidermidis with Reduced Vancomycin Susceptibility  

Nam, Joon-Rok (Department of Neurosurgery, Seoul Paik Hospital Inje University College of Medicine)
Kim, Myoung-Soo (Department of Neurosurgery, Seoul Paik Hospital Inje University College of Medicine)
Lee, Chae-Heuck (Department of Neurosurgery , Seoul Paik Hospital Inje University College of Medicine)
Whang, Dong-Hee (Department of Laboratory Medicine, Seoul Paik Hospital Inje University College of Medicine)
Publication Information
Journal of Korean Neurosurgical Society / v.43, no.6, 2008 , pp. 307-310 More about this Journal
Abstract
Limited therapeutic options are available for vancomycin intermediate-resistant Staphylococcus epidermidis (VISE) infections and no optimum therapy has been established. We report a case of VISE skull osteomyelitis that was successfully treated with linezolid. The patient was a 53-year-old man who presented with headache, nausea and dysphasia. Brain computerized tomography (CT) demonstrated a subdural hematoma in the left hemisphere. Craniotomy and hematoma evacuation was performed and he showed good recovery despite a scalp wound infection caused by methicillin-resistant Staphylococcus aureus (MRSA). The organism isolated from the scalp wound was sensitive to vancomycin. The patient was treated with intravenous vancomycin for 44 days. However, he showed a high fever, persistent positive methicillin-resistant Staphylococcus epidermidis (MRSE) blood cultures, and a deteriorating clinical status. He underwent infected skull bone flap removal and linezolid treatment for 35 days. During one year of follow up, he has not had any further episodes of osteomyelitis or fever. Linezolid has shown to be effective agent to eradiate osteomyelitis caused by VISE.
Keywords
Vancomycin-resistance; Staphylococcus epidermidis; Linezolid; Skull osteomyelitis;
Citations & Related Records

Times Cited By Web Of Science : 3  (Related Records In Web of Science)
Times Cited By SCOPUS : 2
연도 인용수 순위
1 Bodogan B, Appelbaum PC : Oxazolidinones : activitiy, mode of action, and mechanism of resistance. Int J Antimicrob Agents 23 : 113-119, 2004   DOI   ScienceOn
2 Garrett DO, Jochimsen E, Murfitt K, Hill B, McAllister S, Nelson P, et al : The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis. Infect Control Hosp Epidemiol 20 : 167-170, 1999   DOI   ScienceOn
3 Kaatz GW, Seo SM : In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother 40 : 799-801, 1996   PUBMED
4 Schwalbe RS, Ritz WJ, Verma PR, Barranco EA, Gilligan PH : Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus. J Infect Dis 161 : 45-51, 1990   DOI   PUBMED   ScienceOn
5 Schwalbe RS, Stapleton JT, Gilliqan PH : Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med 316 : 927-931, 1987   DOI   PUBMED   ScienceOn
6 Tenover FC, Lancaster MV, Hill BC, Steward CD, Stocker SA, Hancock GA, et al : Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 36 : 1020-1027, 1988
7 Veach LA, Pfaller MA, Barrett M, Koontz FP, Wenzel RP : Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J Clin Microbiol 28 : 2064-2068, 1990   PUBMED
8 Davenport DS, Massanari RM, Pfaller MA, Bale MJ, Streed SA, Hierholzer WJ Jr : Usefulness of a test for slime production as a marker for clinically significant infections with coagulase-negative staphylococci. J Infect Dis 153 : 332-339, 1986   DOI   PUBMED   ScienceOn
9 Rayner CR, Baddour LM, Birmingham MC, Norden C, Meagher AK, Schentag JJ : Linezolid in the treatment of osteomyelitis: results of compassionate use experience. Infection 32 : 8-14, 2004   DOI
10 Farber BF, Kaplan MH, Cloqston AG : Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics. J Infect Dis 161 : 37-40, 1990   DOI   PUBMED   ScienceOn
11 Wong SS, Ho PL, Woo PC, Yuen KY : Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin Infect Dis 29 : 760-767, 1999   DOI   ScienceOn
12 Rana B, Butcher I, Grigoris P, Murnaghan C, Seaton RA, Tobin CM : Linezolid penetration into osteo-articular tissues. J Antimicrob Chemother 50 : 747-750, 2002   DOI   ScienceOn
13 Woodford N, Johnson AP, George RC : Detection of glycopeptide resistance in clinical isolates of gram-positive bacteria. J Antimicrob Chemother 28 : 483-486, 1991   DOI
14 Dunne WM Jr, Qureshi H, Pervez H, Nafziger DA : Staphylococcus epidermidis with intermediate resistance to vancomycin : elusive phenotype or laboratory artifact? Clin Infect Dis 33 : 135-137, 2001   DOI   ScienceOn